Befotertinib trials for Lung cancer

All Befotertinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Befotertinib for Lung cancer

• Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
  NCT06561620 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
  NCT06517953 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
  NCT06863506 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
  NCT07181499 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Befotertinib for Lung cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.